In this article, we examine ongoing challenges shaping target-based drug discovery and highlight how new technologies and ...

A newly identified class of RNA molecules has been discovered in bacteria living inside the human body. These circular ...

Seeking Alpha is proud to welcome Vega North as a new contributing analyst. You can become one too! Share your best ...

Discusses HOPE-3 Phase III Trial Results and Regulatory Path for Duchenne Muscular Dystrophy Therapy December 17, ...

This paper presents an important advance in genetically encoded voltage imaging of the developing zebrafish spinal cord in vivo, capturing voltage dynamics in neuronal populations, single cells, and ...

For decades, depression treatment has focused almost entirely on the brain, with drugs designed to tweak neurotransmitters ...

The authors provide a useful integrated analytical approach to investigating MASLD focused on diverse multiomic integration methods. The strength of evidence for this new resource is solid, as ...

Amphix Bio today announced the initial closing of a $12.5 million seed financing round to advance its lead therapeutic candidates toward human clinical trials and expand its pipeline to target ...

Verastem Oncology , a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced strategic leadership changes to accelerate its ...

In the more than 30 years the Pilatus PC-12 has been in service, its unique combination of speed, load-carrying ability, ...

BioMarin to Gain Galafold® (migalastat) for Fabry Disease and Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) for Pompe Disease, Adding Two Marketed, High-Growth Products with ...

Bipolar Disorder, Digital Phenotyping, Multimodal Learning, Face/Voice/Phone, Mood Classification, Relapse Prediction, T-SNE, Ablation Share and Cite: de Filippis, R. and Al Foysal, A. (2025) ...